LIVE UPDATES: Coronavirus trial tests gout as possible treatment in hospitalized patients

mediabest

Americans remain hopeful for coronavirus vaccine following the Thanksgiving holiday

Internal medicine physician Dr. Shoshana Ungerleider calls recent vaccine developments ‘truly incredible.’

While coronavirus vaccine news has dominated recent pandemic coverage, there is an update on the treatment front as well. 

U.K. researchers leading the Randomized Evaluation of COVID-19 Therapy (RECOVERY) trial which involves hospitalized coronavirus patients have announced that they will begin testing a drug commonly used to treat gout and other inflammatory conditions. 

“Colchicine is an attractive drug to evaluate in the RECOVERY trial as it is very well understood, inexpensive and widely available,” professor Peter Horby, co-chief investigator of the RECOVERY trial, said in a news release. “If it works it would be another COVID-19 treatment that could be used immediately worldwide, even in the poorest countries.”

The news comes weeks after researchers announced they were trialing aspirin. 

Follow below for more coronavirus updates. Mobile users click here.

Source: Read Full Article

Related posts:
  1. Coronavirus vaccine trial: First tested in US yielded antibodies in patients, researchers say
  2. New research finds better drug treatment for miscarriage as patients struggle to access surgery in COVID-19 pandemic
  3. Remdesivir as coronavirus treatment further upheld in study
  4. Coronavirus death toll passes 700: Live updates on 2019-nCoV
  5. Gilead says remdesivir reduces risk of death in coronavirus patients